Br J Cancer 2020 Mar 10
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials.
Related Questions
New answer by Medical Oncologist at MD Anderson Cancer Center (September 23, 2022)
The addition of IO to first-line platinum/etoposide would primarily be an extrapolation of data from small cell lung cancer trials while awaiting the results of the ongoing SW...